公司資料
Merrimack 股價、新聞與催化劑
- 股票代碼:
- MACK
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for MACK.
公司概覽
業務概覽
Merrimack was an oncology company focused on targeted cancer medicines before its corporate restructuring and delisting history. Its legacy was tied to the challenge of turning oncology science into commercial value.
所在地與產業分類
Headquartered in the United States and formerly listed on NASDAQ, Merrimack sat in oncology biotechnology.
商業模式特徵
The business depended on clinical development, commercialization execution, and strategic portfolio decisions.
生技產業定位
Merrimack belongs to the historical oncology-biotech category rather than the current public-company set.
未來催化劑
- Merrimack’s catalysts are zenocutuzumab royalties and any remaining oncology development or monetization update. The market will watch whether the company can keep turning a concentrated asset base into visible value.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。